|
Babalola Chinedum Peace (née Anyabuike) , is a Nigerian Professor of Pharmacy and first female Pharmacist Professor of the University of Ibadan. Her research interest focus on drug analysis, PK/PD pharmacogenetics, Pharmacogenomics, Pharmaceutical analysis and Bioethics. She is the Dean, faculty of Pharmacy and Principal Investigator of the University of Ibadan Centre for Drug discovery, development and production.〔(【引用サイトリンク】title=When UI faculty celebrated 30th year anniversary )〕 She developed a novel High-performance liquid chromatography Method for the analysis of quinine in biometrics. This novel method quinine analysis led to the elucidation of the pharmacokinetics of quinine in Africans and formed the basis of dose optimization in malaria patents. Her feasibility studies on drug interactions and metabolism suggest a decrease in bioavailability and bacterial activity of certain antibiotics when combined with some anti-malaria drugs.〔(【引用サイトリンク】title=Professor Babalola Chinedum Peace )〕 She is one of the scientist that reported the first pharmacogenetic study in healthy and sickle cell patients in Nigerians with pro-guanil as a probe. The report suggested that some Nigerians are carriers of mutant CYP2C19 genes and poor drug metabolizer.〔(【引用サイトリンク】title=Pharmacist tasks colleagues on professionalism )〕 ==Background== 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Babalola Chinedum Peace」の詳細全文を読む スポンサード リンク
|